Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Bioorg Med Chem. 2020 Sep 13;28(23):115762. doi: 10.1016/j.bmc.2020.115762

Table 3.

Inhibition of hFXIa variants by 19S.a

Mutant IC50 (μM) ΔY (%)
FXIaWT 20.0±0.8b 93±3
FXIaA3 14.0±0.4 99±2
FXIaCD 34.0±1.5 96±3
FXIaCD&A3 32.0±1.0 105±3
a

The IC50 and ΔY were calculated following nonlinear regression analysis of direct inhibition of hFXIa mutants (see Methods). Inhibition was monitored by spectrophotometric measurements of residual hFXIa activity.

b

Errors represent ±1 SE.